Effect of Casirivimab/Imdevimab Treatment on Serum Type I Interferon Levels in SARS-CoV-2 Infection

Effect of Casirivimab/Imdevimab Treatment on Serum Type I Interferon Levels in SARS-CoV-2 Infection

The effects of casirivimab and imdevimab (C/I) on the innate immune response against SARS-CoV-2 infection remain unclear. We evaluated the effect of C/I on type I interferon (IFN-I) and cytokines in patients with SARS-CoV-2 infection. This prospective observational study recruited consecutive patien...

Full description

Bibliographic Details
Main Authors: Kentaro Nagaoka, Hitoshi Kawasuji, Yusuke Takegoshi, Yushi Murai, Makito Kaneda, Akitoshi Ueno, Yuki Miyajima, Hideki Niimi, Yoshitomo Morinaga, Yoshihiro Yamamoto
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Viruses
Subjects:
COVID-19
type I interferon
casirivimab
imdevimab
SARS-CoV-2
antibody-dependent enhancement
Online Access:https://www.mdpi.com/1999-4915/14/7/1399

Internet

https://www.mdpi.com/1999-4915/14/7/1399

Similar Items